Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Antibody Technology Market Research Reports

Titlepublishedprice

Anti GM-CSF Antibody -Pipeline Insights, 2016

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Nov-2016$1250

Anti-CD105 Antibody -Pipeline Insights, 2016

By Delve Insight
"...... nical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA desig......"
01-Nov-2016$1250

Anti-CD152 Antibody -Pipeline Insights, 2016

By Delve Insight
"...... nical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA desig......"
01-Nov-2016$1250

Anti-CD19 Antibody -Pipeline Insights, 2016

By Delve Insight
"...... cal, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designa......"
01-Nov-2016$1250

Anti-CD22 Antibody -Pipeline Insights, 2016

By Delve Insight
"...... cal, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designa......"
01-Nov-2016$1250

Anti-CD25 Antibody -Pipeline Insights, 2016

By Delve Insight
"...... cal, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designa......"
01-Nov-2016$1250

Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2016

By Delve Insight
"...... scovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and U......"
01-Nov-2016$1250

Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2016

By Delve Insight
"...... overy, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USF......"
01-Nov-2016$1250

Anti-CD28 Antibody -Pipeline Insights, 2016

By Delve Insight
"...... cal, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designa......"
01-Nov-2016$1250

Anti-CD3 Antibody -Pipeline Insights, 2016

By Delve Insight
"...... l, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designati......"
01-Nov-2016$1250

Avail upto 50% Discount on below Publisher Reports.